Lipoxin A4 and lipoxin A4 receptor expression in induced sputum of asthmatic children

R. Gagliardo, P. Chanez, F. Pompeo, S. La Grutta, L. Siena, M. Profita, A. Bonanno, C. Bonnans, I. Vachier, G. Bonsignore, M. Gjomarkaj (Palermo, Italy; Montpellier, France)

Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Session: New mechanisms in the pathogenesis of asthma and allergy
Session type: Electronic Poster Discussion
Number: 1673
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Gagliardo, P. Chanez, F. Pompeo, S. La Grutta, L. Siena, M. Profita, A. Bonanno, C. Bonnans, I. Vachier, G. Bonsignore, M. Gjomarkaj (Palermo, Italy; Montpellier, France). Lipoxin A4 and lipoxin A4 receptor expression in induced sputum of asthmatic children. Eur Respir J 2007; 30: Suppl. 51, 1673

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of lipoxin A4 in induced sputum of asthmatic children
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008

Lipoxin A4 receptor expression in smokers with and without COPD
Source: Annual Congress 2011 - Novel mechanisms in lung injury
Year: 2011

Anti-inflammatory effect of Lipoxin A4 (LXA4) on human bronchial epithelial cells
Source: Eur Respir J 2002; 20: Suppl. 38, 619s
Year: 2002

Lipoxin A4 regulates bronchial epithelium responses to acid injury
Source: Eur Respir J 2006; 28: Suppl. 50, 660s
Year: 2006

Chronic obstructive pulmonary disease is characterized with suppressed lipoxin A4 and increased lipoxin receptor expression in lungs
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012

Quantitative assessment of cysteinyl leukotrienes in human sputum during the allergen-induced asthmatic response and the effect of GSK2190915, a 5-lipoxygenase activating protein (FLAP) inhibitor
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011

Leukotriene B4 levels in sputum from asthma patients
Source: ERJ Open Res, 2 (4) 00088-2015; 10.1183/23120541.00088-2015
Year: 2016



Upregulation of cysteinyl leukotriene receptors CysLT1 and CysLT2 by TGF-β1 and LTE4 on human bronchial epithelial cells
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006


Increased leukotriene and lower prostaglandin E2 concentrations in induced sputum of patients with eosinophilic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005

The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016


Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in the airway structural cells
Source: Eur Respir J 2005; 26: Suppl. 49, 346s
Year: 2005

Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis
Source: Eur Respir J 2014; 44: 394-404
Year: 2014



Increased expression of the cysteinil leukotriene 1 receptor (CysLT1-R) in the bronchial epithelium of smokers
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001

The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells
Source: Eur Respir J 2003; 22: Suppl. 45, 100s
Year: 2003

Intranasal administration of leukotriene B4 selectively increases human nasal neutrophil activity
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008



Leukotriene C4 synthase polymorphism does not associate with clinical response to leukotriene receptor antagonists in persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 303s
Year: 2002

Leukotriene B4 receptor blockade increases apoptosis of monocyte-derived macrophages from patients with COPD and emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 337s
Year: 2001

Lipoxin and eotaxin as markers of severity in patients with bronchial asthma
Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis
Year: 2008


The effects of a cysteinyl leukotriene receptor antagonist, pranlukast, on dendritic cell chemoattractants in the airways of subjects with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 132s
Year: 2004

Downregulation of prostaglandin E2 in bronchial fibroblasts of asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002